NEW YORK (dpa-AFX) – The US stock exchanges picked up on their weak previous week on the first day of Christmas week. Analyst Craig Erlam from broker Oanda identified several negative factors with the negative effects of the Corona variant Omikron, the monetary policy tightening plans of the major central banks and the impending failure of US President Joe Biden’s social and climate plans. The US bank Goldman Sachs even lowered its growth forecast for the US economy after the Democratic Senator Joe Manchin announced on Sunday that he would not agree to a billion dollar social and climate package.
In view of this mixed situation, the leading index Dow Jones Industrial (Dow Jones 30 Industrial) lost 1.74 percent to 34,750 points a good two and a half hours before the end of the stock market. This brings it back closer to the 200-day line for the longer-term trend. Stocks from the financial and construction sectors made the new economic worries to create: Goldman Sachs, American Express and JPMorgan (JPMorgan ChaseCo) were among the biggest losers in the Dow with discounts of up to 3.6 percent. Caterpillar fell 3.7 percent on the Dow end.
The market-wide S&P 500 slipped 1.65 percent to 4544 points. For the technology-heavy NASDAQ 100, it was down 1.57 percent to 15,554 points.
Investors in the USA could now only cling to the straw that the economic stimulus package will still be successful in a smaller volume in the coming year, said analyst Jochen Stanzl from broker CMC Markets. With reference to Omikron, the economists at Capital Economics said: If worries about this variant should subside, the stock markets should probably regain some ground, but this will probably no longer be a starting signal for another strong price rally.
The software manufacturer Oracle confirmed the takeover of the health software specialist Cerner on Monday. Oracle pays $ 28.3 billion, or $ 95 per share, for this. The Cerner shares, which had already responded to a press report on the subject with a plus of around 13 percent on Friday, gained 0.9 percent, but remained below the purchase price at 90.55 dollars. Oracle lost more than four percent.
Papers from vaccine manufacturers such as Novavax, Moderna and Biontech (BioNTech (ADRs)) turned clearly into the red after initial spa profits. For the recently strong Novavax titles, it was more than five percent. The fact that the EU Medicines Agency EMA paved the way for approval of its vaccine did not have a lasting positive effect./ajx/men
–
TRADE FOREIGN EXCHANGE WITH UP TO LEVER 30 NOW
Trade forex with high leverage and small spreads. With only € 100.00 you can benefit from the effect of € 3,000 in capital.
–
72% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford the high risk of losing your money.
–
– .
